Saskia V Vijver

Innsbruck Medical University — Austria

Immunology and Microbiology · Life Sciences

6h-index290citations16works2.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immune Cell Function and Interaction(10), Immunotherapy and Immune Responses(8), Cancer Immunotherapy and Biomarkers(5), Monoclonal and Polyclonal Antibodies Research(5), vaccines and immunoinformatics approaches(5)

Publications16 total

The scavenger receptor MARCO is a ligand for the immune inhibitory receptor LAIR-1 and regulates its function in cis
Science Signaling·2025
Newly identified oncolytic VSV-GP-specific CD8+ T cell epitopes for monitoring of anti-viral immune responses in the BALB/c mouse model
Molecular Therapy Oncology·2025Open Access
Author response: A novel bioinformatics pipeline for the identification of immune inhibitory receptors as potential therapeutic targets
2024Open Access
A novel bioinformatics pipeline for the identification of immune inhibitory receptors as potential therapeutic targets
eLife·2024· 9 citedOpen Access
A novel bioinformatics pipeline for the identification of immune inhibitory receptors as potential therapeutic targets
2024Open Access
Author response: A novel bioinformatics pipeline for the identification of immune inhibitory receptors as potential therapeutic targets
2024Open Access
A novel bioinformatics pipeline for the identification of immune inhibitory receptors as potential therapeutic targets
eLife·2024· 4 citedOpen Access
Leukocyte-associated immunoglobulin-like receptor-1 blockade in combination with programmed death-ligand 1 targeting therapy mediates increased tumour control in mice
Cancer Immunology Immunotherapy·2024· 8 citedOpen Access
A novel bioinformatics pipeline for the identification of immune inhibitory receptors as potential therapeutic targets
2023Open Access
Prediction and validation of murine MHC class I epitopes of the recombinant virus VSV-GP
Frontiers in Immunology·2023· 6 citedOpen Access
Collagen Fragments Produced in Cancer Mediate T Cell Suppression Through Leukocyte-Associated Immunoglobulin-Like Receptor 1
Frontiers in Immunology·2021· 85 citedOpen Access
Cancer immunotherapy by NC410, a LAIR-2 Fc protein blocking human LAIR-collagen interaction
eLife·2021· 81 citedOpen Access
Author response: Cancer immunotherapy by NC410, a LAIR-2 Fc protein blocking human LAIR-collagen interaction
2021· 6 citedOpen Access
Modulation of the tumor micro-environment by CD8+ T cell-derived cytokines
Current Opinion in Immunology·2021· 50 citedOpen Access
Cancer immunotherapy by NC410, a LAIR-2 Fc protein blocking LAIR-collagen interaction
2020· 1 citedOpen Access
Monitoring Immune Responses in Neuroblastoma Patients during Therapy
Cancers·2020· 40 citedOpen Access

Frequent Co-authors

Akashdip Singh(12), Linde Meyaard(12), M Inês Pascoal Ramos(12), Michiel van der Vlist(7), Alberto Miranda Bedate(6), Helen J. von Richthofen(6), Raphael Kuhn(6), Alexander Yermanos(6), Jürgen Kuball(6), Can Keşmir(6), Dallas B. Flies(5), Sol Langermann(4), Linjie Tian(3), Emma J. de Ruiter(3), Ana Paucarmayta(3), Eline Elshof(3), Jahangheer Shaik(3), Jason Bosiacki(3), Zachary Cusumano(3), Linda Liu(3)